Sakar Healthcare Ltd

NSE: SAKAR · Pharmaceuticals & Biotechnology · 30 announcements

Share price: ₹1,083.70
Market cap: ₹2,411 Cr
Revenue (annual): ₹251.7 Cr
Net profit (annual): ₹30.48 Cr
P/E (TTM): 56.2×Sector 43.8×
Promoter holding: 51.70%-0.82% QoQ
FII holding: 12.34%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Other Announcement 4 Financial Results 4 Results Update 3 Board Meeting Date 3 Management Change 2 Annual General Meeting 2 Regulatory Approval 1 Price Movement Clarification 1 Partnership 1 Capital Structure Change 1 Business Update 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

14 Oct 2026 14:01 IST NSE

Business Update

Sakar Healthcare Business Update

Sakar Healthcare says its oncology export model is expanding, with 22 Marketing Authorizations granted and commercial supply starting from its EU GMP site. No monetary value stated.

Open announcement → Read the filing ↗